166 related articles for article (PubMed ID: 25114540)
21. Off-label intrathecal use of gadobutrol: safety study and comparison of administration protocols.
Halvorsen M; Edeklev CS; Fraser-Green J; Løvland G; Vatnehol SAS; Gjertsen Ø; Nedregaard B; Sletteberg R; Ringstad G; Eide PK
Neuroradiology; 2021 Jan; 63(1):51-61. PubMed ID: 32803338
[TBL] [Abstract][Full Text] [Related]
22. Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study).
Maravilla KR; Smith MP; Vymazal J; Goyal M; Herman M; Baima JJ; Babbel R; Vaneckova M; Žižka J; Colosimo C; Urbańczyk-Zawadzka M; Mechl M; Bag AK; Bastianello S; Bueltmann E; Hirai T; Frattini T; Kirchin MA; Pirovano G
AJNR Am J Neuroradiol; 2015 Jan; 36(1):14-23. PubMed ID: 25300984
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers.
Staks T; Schuhmann-Giampieri G; Frenzel T; Weinmann HJ; Lange L; Platzek J
Invest Radiol; 1994 Jul; 29(7):709-15. PubMed ID: 7960618
[TBL] [Abstract][Full Text] [Related]
24. C-reactive protein levels and clinical symptoms following gadolinium administration in hemodialysis patients.
Schieren G; Tokmak F; Lefringhausen L; van Bracht M; Perings C; Willers R; Günsel A; Kemper F; Wiesmüller GA; Rump LC
Am J Kidney Dis; 2008 Jun; 51(6):976-86. PubMed ID: 18501785
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Unenhanced T1-Weighted Signal Intensities Within the Dentate Nucleus and the Globus Pallidus After Serial Applications of Gadopentetate Dimeglumine Versus Gadobutrol in a Pediatric Population.
Renz DM; Kümpel S; Böttcher J; Pfeil A; Streitparth F; Waginger M; Reichenbach JR; Teichgräber UK; Mentzel HJ
Invest Radiol; 2018 Feb; 53(2):119-127. PubMed ID: 28976476
[TBL] [Abstract][Full Text] [Related]
26. Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.
Lee CH; Vellayappan B; Taupitz M; Hamm B; Asbach P
Eur Radiol; 2019 Dec; 29(12):6982-6990. PubMed ID: 31264013
[TBL] [Abstract][Full Text] [Related]
27. Intra-individual, randomised comparison of the MRI contrast agents gadobutrol versus gadoteridol in patients with primary and secondary brain tumours, evaluated in a blinded read.
Koenig M; Schulte-Altedorneburg G; Piontek M; Hentsch A; Spangenberg P; Schwenke C; Harders A; Heuser L
Eur Radiol; 2013 Dec; 23(12):3287-95. PubMed ID: 23824152
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study].
Vogl TJ; Friebe CE; Balzer T; Mack MG; Steiner S; Schedel H; Pegios W; Lanksch W; Banzer D; Felix R
Radiologe; 1995 Aug; 35(8):508-16. PubMed ID: 7568795
[TBL] [Abstract][Full Text] [Related]
29. 1-molar gadobutrol as a contrast agent for computed tomography: results from a comparative porcine study.
Kalinowski M; Kress O; Wels T; Alfke H; Klose KJ; Wagner HJ
Invest Radiol; 2003 Apr; 38(4):193-9. PubMed ID: 12649642
[TBL] [Abstract][Full Text] [Related]
30. Gadobutrol Precedes Gd-DTPA in Abdominal Contrast-Enhanced MRA and MRI: A Prospective, Multicenter, Intraindividual Study.
Liu X; Li Z; Zhang W; Yang C; Diao Y; Duan T; Fu Y; Ren J; Bin S
Contrast Media Mol Imaging; 2019; 2019():9738464. PubMed ID: 31866800
[TBL] [Abstract][Full Text] [Related]
31. Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
Robert P; Vives V; Grindel AL; Kremer S; Bierry G; Louin G; Ballet S; Corot C
Radiology; 2020 Jan; 294(1):117-126. PubMed ID: 31660804
[TBL] [Abstract][Full Text] [Related]
32. Post-marketing surveillance of gadobutrol for contrast-enhanced magnetic resonance imaging in Japan.
Tsushima Y; Awai K; Shinoda G; Miyoshi H; Chosa M; Sunaya T; Endrikat J
Jpn J Radiol; 2018 Nov; 36(11):676-685. PubMed ID: 30232584
[TBL] [Abstract][Full Text] [Related]
33. Safety of contrast-enhanced MR angiography employing gadobutrol 1.0 M as contrast material.
Balzer JO; Loewe C; Davis K; Goyen M; Leiner T; Meaney JF; Pöckler-Schöniger C; Schulte-Altedorneburg G; Tombach B; Vosshenrich R; Wegener R
Eur Radiol; 2003 Sep; 13(9):2067-74. PubMed ID: 12928957
[TBL] [Abstract][Full Text] [Related]
34. Improved display of abdominal contrast-enhanced MRA using gadobutrol: comparison with Gd-DTPA.
Liu X; Zhang W; Li Z; Fu Y; Ren J; Shen W; Wang J; Xu Y; Song B
Clin Radiol; 2019 Dec; 74(12):978.e1-978.e7. PubMed ID: 31551147
[TBL] [Abstract][Full Text] [Related]
35. Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.
Anzalone N; Scarabino T; Venturi C; Cristaudo C; Tartaro A; Scotti G; Zimatore D; Floris R; Carriero A; Longo M; Cirillo M; Cova MA; Gatti S; Voth M; Colosimo C
Eur J Radiol; 2013 Jan; 82(1):139-45. PubMed ID: 21890295
[TBL] [Abstract][Full Text] [Related]
36. Dynamic magnetic resonance imaging of the breast: Comparison of gadobutrol vs. Gd-DTPA.
Escribano F; Sentís M; Oliva JC; Tortajada L; Villajos M; Martín A; Ganau S
Radiologia (Engl Ed); 2018; 60(1):49-56. PubMed ID: 29217300
[TBL] [Abstract][Full Text] [Related]
37. Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T.
Wildgruber M; Stadlbauer T; Rasper M; Hapfelmeier A; Zelger O; Eckstein HH; Halle M; Rummeny EJ; Huber AM
Invest Radiol; 2014 Nov; 49(11):728-34. PubMed ID: 24872002
[TBL] [Abstract][Full Text] [Related]
38. P03277-A New Approach to Achieve High-Contrast Enhancement: Initial Results of an Experimental Extracellular Gadolinium-Based Magnetic Resonance Contrast Agent.
Fries P; Müller A; Seidel R; Robert P; Denda G; Menger MD; Schneider G; Buecker A
Invest Radiol; 2015 Dec; 50(12):835-42. PubMed ID: 26186281
[TBL] [Abstract][Full Text] [Related]
39. MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
Saake M; Langner S; Schwenke C; Weibart M; Jansen O; Hosten N; Doerfler A
Eur Radiol; 2016 Mar; 26(3):820-8. PubMed ID: 26123410
[TBL] [Abstract][Full Text] [Related]
40. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine.
Durmus T; Schilling R; Doeblin P; Huppertz A; Hamm B; Taupitz M; Wagner M
Invest Radiol; 2012 Mar; 47(3):183-8. PubMed ID: 22183078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
